Business
Verde Media Group, Inc. Biotech Division Announces Over-Lapping Technology For Purified Marijuana Products And Omega-3 Proteins
Verde Media Group, Inc. Biotech Division Announces Over-Lapping Technology For Purified Marijuana Products And Omega-3 Proteins.
About this update from Cbd Of Denver Inc.
[{"type":"text","content":"\n\n\n\nVerde Media Group, Inc. Biotech Division Announces Over-Lapping Technology For Purified Marijuana Products And Omega-3 Proteins\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prnml{\nTEXT-ALIGN: left; WIDTH: 100%\n}\n\n\n\n\n\n\nVerde Media Group, Inc. Biotech Division Announces Over-Lapping Technology For Purified Marijuana Products And Omega-3 Proteins\nPR Newswire\nLOS ANGELES, Feb. 28, 2014\n\n\n\nLOS ANGELES, Feb. 28, 2014 /PRNewswire/ -- Verde Media Group Inc. (OTC: VMGI) has announced the formation of the Verde Media Biotechnology Division (\"VMBD\"). \n\nThe VMBD division will undertake the business of developing and producing high value bio-products from renewable biomass. The focus and criterion is to develop proprietary technologies with low risk of scale-up utilizing low cost feedstock. After successful production at demonstration scale such technologies and products will be licensed and sold to third parties globally. \n\nVMBD will initially focus on two high value products with an over-lapping technology platform. First is the high density microbial production of Omega-3 oil. The market for eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) Omega-3 products measured by global consumer spending on EPA/DHA fortified products was $25.4 billion in 2011 for the six following categories: infant formula; fortified foods and beverages; nutritional supplements; pharmaceuticals; clinical nutrition; and pet food, treats and supplements. The projected market value of EPA/ DHA Omega-3 products will reach $34.7 billion in 2016 with a continued accelerated growth rate over the next 5 years. \n\nSecondly, the technology division will develop platform technologies for extracting highly purified forms of cannabis-based phytocannabinoids products, including D9 tetrahydrocannabinol (THC) and cannabidiol (CBD). VMBD will develop the derivative and ester forms of THC for increase potency and their use in different delivery systems, including sublingual, inhaled dosage forms and blending with food products. \n\nThe initial core team consists of experienced scienti...